The place for (tech) startups! Click here for our offer in ALPHA

Ambagon Therapeutics (based in hub Catalyst) raises $85 million

ambagon c2w

Ambagon Therapeutics, a biotechnology company (spinn off from TU/e) based in hub Catalyst on the TU/e campus since last year, yesterday raised a Series A worth $85 million to expand its modular drug research platform. Congratulations to team Ambagon! The financing was led by Nextech Invest. Ambagon was previously set up by RA Capital [...]